Abstract
Several families of short and long interspersed DNA elements (SINEs and LINEs) inhabit mammalian genomes. Amplification of these elements (which can exceed one million copies) has occurred primarily by an RNA-mediated mechanism referred to as retroposition (or retrotransposition). When integrated into a gene, these elements may cause deleterious effects to the individual organism, as exemplified in various human disorders. Alternatively, several integration-recipient genes with altered function or expression are evolutionarily conserved within or among species. Experimental analyses further demonstrate effects of gene regulation by retroposed elements. Although most integrations apparently have no significant impact on the phenotype of various mammalian species, the accumulation of SINEs and LINEs provides a multitude of sites for homologous recombination and yields a considerable proportion of methylation sites in mammalian genomes. Specific and cumulative integrations may provide an integral component in the speciation process. This review examines the functional and regulatory impact of retroposon integrations on individual genes, the impact of accumulated integration events, and the evidence for the role of these elements in the evolution of species. Since these elements continue to integrate into mammalian genomes, it is important to further understand and evaluate their functional impact.
Keywords: SINEs, LINEs, Neurofibromatosis, Apert Syndrome, Alport Syndrome, Gyrate Atrophy of Choroid, Spastic, Canine Transmissible venereal tumor, Hemophilia
Current Genomics
Title: Impact of SINEs and LINEs on the Mammalian Genome
Volume: 2 Issue: 2
Author(s): H. D. Kass
Affiliation:
Keywords: SINEs, LINEs, Neurofibromatosis, Apert Syndrome, Alport Syndrome, Gyrate Atrophy of Choroid, Spastic, Canine Transmissible venereal tumor, Hemophilia
Abstract: Several families of short and long interspersed DNA elements (SINEs and LINEs) inhabit mammalian genomes. Amplification of these elements (which can exceed one million copies) has occurred primarily by an RNA-mediated mechanism referred to as retroposition (or retrotransposition). When integrated into a gene, these elements may cause deleterious effects to the individual organism, as exemplified in various human disorders. Alternatively, several integration-recipient genes with altered function or expression are evolutionarily conserved within or among species. Experimental analyses further demonstrate effects of gene regulation by retroposed elements. Although most integrations apparently have no significant impact on the phenotype of various mammalian species, the accumulation of SINEs and LINEs provides a multitude of sites for homologous recombination and yields a considerable proportion of methylation sites in mammalian genomes. Specific and cumulative integrations may provide an integral component in the speciation process. This review examines the functional and regulatory impact of retroposon integrations on individual genes, the impact of accumulated integration events, and the evidence for the role of these elements in the evolution of species. Since these elements continue to integrate into mammalian genomes, it is important to further understand and evaluate their functional impact.
Export Options
About this article
Cite this article as:
Kass D. H., Impact of SINEs and LINEs on the Mammalian Genome, Current Genomics 2001; 2 (2) . https://dx.doi.org/10.2174/1389202013350968
DOI https://dx.doi.org/10.2174/1389202013350968 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced AI Techniques in Big Genomic Data Analysis
The thematic issue on "Advanced AI Techniques in Big Genomic Data Analysis" aims to explore the cutting-edge methodologies and applications of artificial intelligence (AI) in the realm of genomic research, where vast amounts of data pose both challenges and opportunities. This issue will cover a broad spectrum of AI-driven strategies, ...read more
Advanced Computational Algorithms and Artificial Intelligence in Clinical Pharmacogenomics
In the era of personalized medicine, understanding the relationship between genetics and drug response is crucial. This issue delves into innovative methodologies, leveraging deep computational analysis and artificial intelligence, to enhance the field of Clinical Pharmacogenomics. The interdisciplinary approach harnesses the power of advanced high-throughput genotyping technologies, sophisticated computational analysis, ...read more
Applications of Single-cell Sequencing Technology in Reproductive Medicine
Single cell sequencing (SCS) technology utilizes individual cells' genetic material to sequence their genome, transcriptome, and epigenetics at the molecular level. It offers insights into cell heterogeneity and enables the study of limited biological materials. Since its recognition as a valuable technique in 2011, single cell sequencing has yielded numerous ...read more
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Related Journals
![](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Molecular Targets in Osteoarthritis: Metalloproteinases and Their Inhibitors
Current Drug Targets An Insight into the Role of E2F1 in Breast Cancer Progression, Drug Resistance, and Metastasis
Current Molecular Medicine Role of Estradiol and Progesterone in HIV Susceptibility and Disease Progression
Mini-Reviews in Medicinal Chemistry Stem Cells Derived from Human Exfoliated Deciduous Teeth (SHED) in Neuronal Disorders: A Review
Current Stem Cell Research & Therapy The Impacts of Non-coding RNAs and N<sup>6</sup>-Methyladenosine on Cancer: Past, Present and Future
Current Cancer Drug Targets Caveats Regarding the Use of IL-10 and IL-10 Antagonist as Immunotherapeutic Factors
Letters in Drug Design & Discovery Administration of Exogenous Surfactant and Cytosolic Phospholipase A2α Inhibitors may Help COVID-19 Infected Patients with Chronic Diseases
Coronaviruses Structure-Affinity-Relationship Study of Bicyclic σ Receptor Ligands
Central Nervous System Agents in Medicinal Chemistry Triggered Activation and Release of Liposomal Prodrugs and Drugs in Cancer Tissue by Secretory Phospholipase A2
Current Drug Delivery Synthesis of N-acyl Derivatives of Aminocombretastatin A-4 and Study of their Interaction with Tubulin and Downregulation of c-Myc
Medicinal Chemistry Current Advances in Drug Design and Cancer Research
Current Topics in Medicinal Chemistry Design and Virtual Screening Towards Synthesis of Novel Substituted Thiosemicarbozones as Ribonuleotide Reductase (RNR) Inhibitors with Improved Cellular Trafficking and Anticancer Activity
Current Topics in Medicinal Chemistry Do Chromatin Interaction Networks Radiate Pathogenic Contagion in the Genome?
Epigenetic Diagnosis & Therapy (Discontinued) Patent Selections:
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Indoleamine 2,3-Dioxygenase, an Emerging Target for Anti-Cancer Therapy
Current Cancer Drug Targets miR-137 Suppresses the Phosphorylation of AKT and Improves the Dexamethasone Sensitivity in Multiple Myeloma Cells Via Targeting MITF
Current Cancer Drug Targets Adenoviral Vectors for Cancer Gene Therapy
Current Genomics Cancer Stem-Cells Patents in the Context of their Therapeutic Purposes: Exploring the Latest Trends (2011-2015)
Recent Patents on Regenerative Medicine Proteinase-Activated Receptor-2: Physiological and Pathophysiological Roles
Current Medicinal Chemistry - Cardiovascular & Hematological Agents The Clinical Prognostic Value of LRG1 in Esophageal Squamous Cell Carcinoma
Current Cancer Drug Targets